Results: A high dose of DM significantly produced serotonin syndrome in mice. In addition, treatment with DM resulted in a significant increase in 5-HT1A receptor mRNA expression but not that of 5-HT2A receptor in the hypothalamus of mice. Furthermore, WAY100635, but not MDL11939, significantly attenuated increases in hypothalamic serotonin level, serotonergic behaviors and hypothermia induced by DM. Conclusion: Up-regulation of 5-HT1A receptor is essential for serotonin syndrome induced by DM in mice [This study was supported by a grant (14182MFDS979) from the Korea Food and Drug Administration, Republic of Korea].
Methods: Mice were pretreated with rottlerin, a pharmacological inhibitor of PKC-δ, 30 min before DM administration. Scores of serotonin syndrome (i.e. reciprocal forepaw treading, lateral head-weaving, hind-limb abduction, tremor, Straub tail and flat body posture) were assessed during 30 min after DM. In addition, rectal temperature was measured 30 min after DM. Serotonin levels and 5-HT1A receptor mRNA expression were examined in the hypothalamus 2 h after DM. Results: A high dose of DM resulted in a specific induction of PKC-δ out of PKC-α, PKC-β1, PKC-β2, PKC-ξ, PKC-δ in the hypothalamus of mice. Rottlerin significantly attenuated serotonergic behaviors induced by DM. In addition, rottlerin protected increases in 5-HT1A receptor mRNA expression and serotonin level induced by DM in wild-type mice. Consistently, genetic inhibition of PKC-δ protected serotonergic behaviors and increases in serotonin level, mRNA expression of 5-HT1A receptor induced by DM. Conclusion: Endogenous PKC-δ gene mediates serotonin syndrome induced by DM in mice [This study was supported by a grant (14182MFDS979) from the Korea Food and Drug Administration, Republic of Korea].
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PKCδ gene facilitates cognitive impairment induced by low doses of methamphetamine (MA) in mice We suggested that the cognitive impairment induced by repeated MA treatment in mice is a useful model of the cognitive deficits in schizophrenia and MA psychosis. We also demonstrated that minocycline, an antibiotic possessing antiinflammatory activity, improves cognitive impairment induced by MA. It is well-known that protein kinase C (PKC) mediates neuroinflammation. Therefore, we investigated a specific role of PKC in response to cognitive impairment induced by MA. Method: To achieve a better understanding whether PKC expression can be altered by repeated treatment with MA. We examined changes in the expression of PKCα, PKCβ 1 , PKCβ 2 , PKCζ, and PKCδ in the prefrontal cortex (PFC) after the final MA treatment. Because PKCδ expression is selectively increased after the last MA, we applied PKCδ knock-out (KO) mice in this study. We evaluated relationship between novel object recognition test (NORT), phosphorylation of extracellular signal-regulated kinase ½ (p-ERK½), and phosphorylation of PKCδ (p-PKCδ) in the PFC. Result: Repeated treatment with MA resulted in cognitive impairment as evaluated by NORT. This effect lasted, at least, for 28 days after the final MA treatment. Correlation study indicated that cognitive impairment parallels p-PKCδ expression. P-ERK½ expression increased in the mice exposed to the novel objects in the absence of MA, but it was decreased in the presence of MA. 
